URC Raises US$22.9M in Bought Deal Financing, Dilution Risk
Ticker: UROY · Form: 6-K · Filed: Feb 2, 2024 · CIK: 1711570
| Field | Detail |
|---|---|
| Company | Uranium Royalty CORP. (UROY) |
| Form Type | 6-K |
| Filed Date | Feb 2, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | mixed |
Complexity: simple
Sentiment: mixed
Topics: bought-deal, financing, equity-offering, dilution
TL;DR
**URC is raising US$22.9M by selling new shares, expect potential dilution.**
AI Summary
Uranium Royalty Corp. (URC) announced a bought deal financing on February 2, 2024, agreeing to sell 6,724,600 common shares at US$3.40 per share, raising approximately US$22.9 million. This capital raise, expected to close around February 9, 2024, could dilute existing shareholders' ownership percentage, but provides URC with significant funds for future investments or operations, potentially strengthening its position in the uranium market.
Why It Matters
This financing provides Uranium Royalty Corp. with a substantial cash injection, which can be used to acquire new royalties or streams, but it also means more shares are outstanding, potentially diluting the value of existing shares.
Risk Assessment
Risk Level: medium — The offering introduces new shares, which typically dilutes existing shareholder value, but the capital raised could also fund growth opportunities.
Analyst Insight
An investor should monitor URC's stock performance around the closing date of February 9, 2024, for potential short-term price fluctuations due to dilution, while also evaluating how the US$22.9 million in new capital will be deployed for future growth.
Key Numbers
- $22.9M — Gross Proceeds (Amount raised by Uranium Royalty Corp. from the share offering.)
- 6,724,600 — Common Shares (Number of shares sold in the bought deal financing.)
- $3.40 — Price Per Share (The price at which each common share was sold in the offering.)
- 15% — Over-allotment Option (Additional shares underwriters can purchase to cover over-allotments.)
Key Players & Entities
- Uranium Royalty Corp. (company) — the registrant and issuer of shares
- Canaccord Genuity Corp. (company) — sole bookrunner for the financing
- Josephine Man (person) — Chief Financial Officer who signed the filing
- US$22.9 million (dollar_amount) — gross proceeds from the bought deal financing
- 6,724,600 (dollar_amount) — number of common shares sold in the offering
- US$3.40 (dollar_amount) — price per common share in the offering
- February 2, 2024 (date) — date of the press release and filing
- February 9, 2024 (date) — expected closing date of the offering
Forward-Looking Statements
- Uranium Royalty Corp.'s share price may experience short-term downward pressure due to the increased supply of shares from the offering. (Uranium Royalty Corp.) — medium confidence, target: February 2024
- The capital raised will enable URC to pursue new royalty or streaming agreements, potentially expanding its asset portfolio. (Uranium Royalty Corp.) — high confidence, target: Next 6-12 months
FAQ
What is the total gross proceeds Uranium Royalty Corp. expects to receive from this bought deal financing?
Uranium Royalty Corp. expects to receive approximately US$22.9 million in gross proceeds from this offering, as stated in the filing.
How many common shares is Uranium Royalty Corp. selling in this offering and at what price per share?
The company is selling 6,724,600 common shares at a price of US$3.40 per common share, according to the filing.
Who is leading the syndicate of underwriters for this financing?
Canaccord Genuity Corp. is leading the syndicate of underwriters as the sole bookrunner for this financing, as mentioned in the Exhibit 99.1 press release.
When is the offering expected to close?
The offering is expected to close on or about February 9, 2024, as stated in the press release.
Does the company grant the underwriters an option for additional shares, and if so, what are the terms?
Yes, the company has granted the underwriters an option to purchase up to an additional 15% of the offering at the offering price for a period of 30 days after and including the closing of the Offering, to cover over-allotments.
Filing Stats: 155 words · 1 min read · ~1 pages · Grade level 11.3 · Accepted 2024-02-02 10:39:30
Filing Documents
- form6-k.htm (6-K) — 14KB
- ex99-1.htm (EX-99.1) — 12KB
- 0001493152-24-004679.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Uranium Royalty Corp. Date: February 2, 2024 By: /s/ Josephine Man Name: Josephine Man Title: Chief Financial Officer EXHIBIT INDEX Exhibit Description of Exhibit 99.1 Press Release dated February 2, 2024